PG E2: A Potent Mediator of Pain, Inflammation and Angiogenesis

Target Name: PTGER4

NCBI ID: G5734

PTGER4

PG E2: A Potent Mediator of Pain, Inflammation and Angiogenesis

Prostaglandin E2 (PGE2) is a potent mediator of pain, inflammation, andangiogenesis. It is a potent synthetic derivative of prostaglandin E1 (PGE1), which is a potent vasoactive agent involved in the regulation of blood flow and is involved in the development of pain, inflammation, and fibrosis. PG E2 is found in various tissues and cells, including the brain, kidneys, heart, and intestines, and is involved in the regulation of pain perception, inflammation, and the maintenance of tissue homeostasis.

One of the main roles of PG E2 is its role in pain modulation. PG E2 is involved in the regulation of pain perception and neuropeptide-mediated pain modulation. It is well documented that PG E2 is involved in the modulation of pain perception and that its levels are elevated in individuals with chronic pain conditions.

PG E2 is also involved in the regulation of inflammation. It is a potent vasoactive agent and increases blood flow to the site of inflammation, which allows for an increase in the delivery of immune cells and inflammatory mediators to the site of inflammation. This increase in inflammatory mediators contributes to the development of inflammation and tissue damage.

PG E2 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. It is a potent vasoactive agent and increases blood flow to the site of angiogenesis, which allows for the formation of new blood vessels. This increase in blood flow to the site of angiogenesis contributes to the development of new blood vessels and the growth of tissues.

PG E2 is also involved in the regulation of tissue homeostasis. It is a potent vasoactive agent and increases blood flow to the site of tissue damage, which allows for the delivery of immune cells and the removal of damaged tissue. This increase in blood flow to the site of tissue damage contributes to the regulation of tissue homeostasis.

In addition to its role in pain modulation, inflammation, and tissue homeostasis, PG E2 is also involved in the regulation of various other physiological processes. It is involved in the regulation ofmobility, the regulation of sensations, and the regulation of the nervous system.

Despite its involvement in a wide range of physiological processes, PG E2 is not well understood. There is a need for further research to fully understand its role in these processes and to develop new treatments based on its properties.

One potential approach to treating PG E2-related conditions is to target it directly with small molecules. This can be done by identifying small molecules that inhibit the activity of PG E2 or by identifying small molecules that activate its activity. This can lead to the development of new treatments for chronic pain conditions, such as neuropathic pain, chronic inflammation, and fibrosis.

Another approach to treating PG E2-related conditions is to target its metabolites. PG E2 is metabolized to several metabolites, including 2-prostaglandin E1 (2-PGE1), 10-prostaglandin E1 (10-PGE1), and 11-prostaglandin E1 (11-PGE1). These metabolites also have important roles in pain modulation and inflammation. Targeting these metabolites may lead to the development of new treatments for chronic pain conditions and other inflammatory conditions.

In conclusion, PG E2 is a potent mediator of pain, inflammation, and angiogenesis. It is involved in the regulation of pain perception, inflammation, and tissue homeostasis, and there is a need for further research to fully understand its role in these processes. Targeting PG E2 directly with small molecules or its metabolites may lead to the development of new treatments for chronic pain conditions and other inflammatory conditions.

Protein Name: Prostaglandin E Receptor 4

Functions: Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function

The "PTGER4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTGER4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets